VION Biosciences Acquires Second Asset in August, Immunoassay Development Company Ansh Labs

Acquisition drives synergy within existing VION platform and creates greater opportunity to serve diagnostic market CHARLOTTESVILLE, Va. -- VION Biosciences, a life science platform company focused on specialty materials in the life science research, diagnostic, and drug discovery spaces, announces its second acquisition this August with the acquisition of Ansh Labs, a biotechnology company that [...]

Nikon Announces New Image Analysis Functions to Empower Drug Discovery Research for Cancer, Neurological Disease, and Regenerative Medicine

New software updates bring expanded capability to the ECLIPSE Ji smart imaging system MELVILLE, NY – Nikon Instruments Inc. (Nikon) is pleased to announce a new software update for the ECLIPSE Ji smart imaging system (compatible with NIS-Elements ver. 6.10 onward) that brings a variety of broadened experimental capabilities to areas such as oncology, neurology, and regenerative medicine. The [...]

ThinkCyte Secures $32 million in Series C Funding to Drive Global Expansion of VisionSort™

Tokyo, Japan. / Redwood City, CA -- ThinkCyte today announced the successful completion of its Series C funding round. Including the equity financing secured last November, the company raised an additional $15 million in the extension round, bringing the total to $32 million. The extension round was led by Japan Green Investment Corp. for Carbon Neutrality [...]

Biognosys Announces Commercial Availability of NULISA™ Proteomics Assay Services for Biomarker Research

Under a strategic partnership with Alamar Biosciences, Biognosys is a provider of choice of NULISA multiplex assay services for biopharma research   The NULISAseq™ CNS Disease and Inflammation panels are now available for customers as a contract research service from Biognosys’ high-end proteomics facility in Europe  By offering the combination of NULISA affinity-based assays and TrueDiscovery® mass [...]

Acceleration of Bioprocess Development: IRUBIS secures Pre-Series A Funding led by BioProcess360 Partners

Munich, DE – Biotech startup IRUBIS, developing a state-of- the - art real - time bioprocess monitoring solution, has successfully closed a pre- series A funding round. The financing round was led by BioProcess360 Partners, with participation from previous investors such as High-Tech Gründerfonds (HTGF), Verve Ventures, Ventura BioMed Investors, RoBet KG as well as [...]

BC Platforms Announces Appointment of New Chairperson Dr. Jan Berger, Seasoned Executive and Strategist, to Drive Strategic Agenda

BC Platforms, a global leader in real world data, healthcare data management, and analytics, today announces the appointment of a new Chairperson of the Board. Jan Berger is a seasoned executive with deep experience at the intersection of healthcare, life sciences, and information technology. Under her leadership BC Platforms continues to drive growth in the global markets [...]

Sensific GmbH and Microblox Announce Strategic Partnership to Bring Cutting-Edge Microfluidics Solutions to China

Sensific GmbH, a German leader in advanced optical measurement and automation systems, is pleased to announce a strategic partnership with 微纳立方科技(北京)有限公司 (Microblox), a premier provider of comprehensive microfluidics laboratory solutions in China. This collaboration will see Microblox become the official distributor of Sensific’s innovative microfluidics-based products across the Chinese market. Sensific GmbH is renowned for its pioneering [...]

Cygnus Technologies and TriLink BioTechnologies® Collaborate to Launch AccuRes™ Host Cell DNA Quantification Kits

Cygnus’ AccuRes Kits to recover, amplify, & quantify remaining host cell DNA during biologic drug manufacturing to produce safer, more stable vaccines, therapies, and more LELAND, N.C. & SAN DIEGO -- Cygnus Technologies (Cygnus), TriLink BioTechnologies (TriLink®), both part of Maravai LifeSciences (NASDAQ: MRVI) have collaborated to launch Cygnus’ AccuRes™ Host Cell DNA Quantification Kits. Together, the companies have [...]

CALIBRE SCIENTIFIC ACQUIRES CONEX CHROMATOGRAPHY SYSTEMS

CALIBRE SCIENTIFIC ACQUIRES CONEX CHROMATOGRAPHY SYSTEMS, A UK PROVIDER OF CHROMATOGRAPHY INSTRUMENTS, CONSUMABLES AND SERVICES LOS ANGELES, CA — Calibre Scientific is pleased to announce the acquisition of Conex Chromatography Systems Limited (“Conex” or the “Company”), a provider of chromatography instruments, consumables, and services catering to life sciences, pharmaceutical, academic, petrochemical, nuclear energy, and the [...]

SmiLe Inject Capital Invests 9 Million SEK in Three Groundbreaking Life Science Startups

Thomas Unt, the CEO of SmiLe Inject Capital Lund, Sweden – SmiLe Inject Capital, an investment company under the SmiLe Venture Hub umbrella, is investing a total of 9 million SEK (0,8 million euros) in three promising life science startups: Uman Sense, Nygen Analytics, and Aligned Bio. All three companies are members of SmiLe and [...]

Access IBO on Knowledge Center